At this time, posts about Mezzion are rapidly increasing on portals and securities communities. Today, foreigners have net sold 29,000 shares of Mezzion, and institutions have net sold 1,000 shares, according to preliminary data. Mezzion is known as a company specializing in new drug development.


As of 11:30 AM on the 31st, Mezzion's stock price is 170,600 KRW, down 24.14% from the previous day, with a trading volume of 2,889,220 shares, which is 1013.29% of the 5-day average trading volume. On August 24, Mezzion was a market issue with a 9% rise on expectations for 'Udenafil.'


In addition to Mezzion, posts by investors are also rapidly increasing for Sinsung ENG (011930), KG Mobilians (046440), and PharmAbcine (208340).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing